Lumos Pharma LUMO 深 滬
已收盤 12-12 16:00:00 美东时间
4.34
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 4.34
- 總市值 3753.50万
- 52周最高 4.5756
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 1.3701
- 委 比 0.00%
- 總股本 864.86万
- 歷史最高 528.57
- 量 比 0
- 振 幅 0.00%
- 歷史最低 1.3701
- 每 手 1
- 風險率 0.00%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Lumos Pharma Completes Merger and Delisting Process
The latest update is out from Lumos Pharma ( ($LUMO) ). Lumos Pharma, Inc. has ...
2024-12-12 23:47
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LUMO, ALTR, STAF on Behalf of Shareholders
NEW YORK, Nov. 12, 2024 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or...
2024-11-13 04:27
Lumos Pharma Faces Uncertainty as CVRs Risk Expiring Worthless Post-Merger
Lumos Pharma, Inc. (LUMO) has disclosed a new risk, in the Share Price & Sh...
2024-11-09 14:01
快讯 | lumos pharma宣布其两个摘要已被接受，并将在2024年第62届ESPE年会上进行口头报告
Lumos Pharma Announces Two Abstracts Accepted for Oral Presentation at the 62ⁿᵈ...
2024-10-31 04:05
快讯 | Lumos Pharma, Inc.：H.C. Wainwright将目标价从$28降至$4.25
Lumos Pharma, Inc. : H.c. Wainwright Cuts Target Price to $4.25 From $28
2024-10-24 18:04
Lumos inks take-private deal with Double Point Ventures
Lumos Pharma (NASDAQ:LUMO) announced Wednesday a merger agreement with Double Point Ventures, under which the Florida-based venture capital firm is set to acquire the biotech in a take-private deal. P...
2024-10-23 20:24
Analysts Offer Insights on Healthcare Companies: Lumos Pharma (LUMO) and Rani Therapeutics Holdings (RANI)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts jus...
2024-08-07 21:50
Oppenheimer Maintains Outperform on Lumos Pharma, Lowers Price Target to $13
Oppenheimer analyst Leland Gershell maintains Lumos Pharma (NASDAQ:LUMO) with a Outperform and lowers the price target from $16 to $13.
2024-08-02 23:50
快讯 | Lumos Pharma Inc.：Oppenheimer将目标价从16美元下调至13美元。
Lumos Pharma Inc. : Oppenheimer Cuts Target Price to $13 From $16
2024-08-02 20:10
